Alison Wichman

1.2k total citations
29 papers, 864 citations indexed

About

Alison Wichman is a scholar working on Public Health, Environmental and Occupational Health, Pathology and Forensic Medicine and General Health Professions. According to data from OpenAlex, Alison Wichman has authored 29 papers receiving a total of 864 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Public Health, Environmental and Occupational Health, 5 papers in Pathology and Forensic Medicine and 5 papers in General Health Professions. Recurrent topics in Alison Wichman's work include Ethics in Clinical Research (7 papers), Multiple Sclerosis Research Studies (5 papers) and Ethics in medical practice (5 papers). Alison Wichman is often cited by papers focused on Ethics in Clinical Research (7 papers), Multiple Sclerosis Research Studies (5 papers) and Ethics in medical practice (5 papers). Alison Wichman collaborates with scholars based in United States, Sweden and Mexico. Alison Wichman's co-authors include David S. Krantz, Eddie Reed, Henry Masur, Margaret A. Fischl, Samuel Broder, G. R. van den Berg, Robert Yarchoan, Rose V. Thomas, Jordan Grafman and Charles E. Myers and has published in prestigious journals such as The Lancet, Circulation and Nature Communications.

In The Last Decade

Alison Wichman

28 papers receiving 818 citations

Peers

Alison Wichman
Sonya J. Snedecor United States
Gayle Cocita Baldwin United States
Lucy Civitello United States
Eun-Sook Cho South Korea
Kathleen Costello United States
Joseph Sebastian United States
Roger Mills United Kingdom
Sonya J. Snedecor United States
Alison Wichman
Citations per year, relative to Alison Wichman Alison Wichman (= 1×) peers Sonya J. Snedecor

Countries citing papers authored by Alison Wichman

Since Specialization
Citations

This map shows the geographic impact of Alison Wichman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alison Wichman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alison Wichman more than expected).

Fields of papers citing papers by Alison Wichman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alison Wichman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alison Wichman. The network helps show where Alison Wichman may publish in the future.

Co-authorship network of co-authors of Alison Wichman

This figure shows the co-authorship network connecting the top 25 collaborators of Alison Wichman. A scholar is included among the top collaborators of Alison Wichman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alison Wichman. Alison Wichman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kósa, Péter, et al.. (2022). Molecular models of multiple sclerosis severity identify heterogeneity of pathogenic mechanisms. Nature Communications. 13(1). 7670–7670. 13 indexed citations
2.
Kósa, Péter, Tianxia Wu, Jonathan A. Phillips, et al.. (2020). Idebenone does not inhibit disability progression in primary progressive MS. Multiple Sclerosis and Related Disorders. 45. 102434–102434. 26 indexed citations
3.
Kósa, Péter, et al.. (2018). NeurEx: digitalized neurological examination offers a novel high‐resolution disability scale. Annals of Clinical and Translational Neurology. 5(10). 1241–1249. 15 indexed citations
4.
Kósa, Péter, et al.. (2018). Identifying and Quantifying Neurological Disability via Smartphone. Frontiers in Neurology. 9. 29 indexed citations
5.
Weideman, Ann Marie, Péter Kósa, Mika Komori, et al.. (2017). New Multiple Sclerosis Disease Severity Scale Predicts Future Accumulation of Disability. Frontiers in Neurology. 8. 598–598. 31 indexed citations
6.
Allison, Robert D., et al.. (2008). Roles and Experiences of Non-scientist Institutional Review Board Members at the National Institutes of Health. PubMed Central. 5 indexed citations
7.
Wichman, Alison, et al.. (2006). Protecting human subjects in the NIH's Intramural Research Program: a draft instrument to evaluate convened meetings of its IRBs.. PubMed. 28(3). 7–10. 6 indexed citations
8.
Stevenson, Lynne W., Robert L. Kormos, Mark L. Barr, et al.. (2001). Mechanical Cardiac Support 2000: Current Applications and Future Trial Design. Circulation. 103(2). 337–342. 49 indexed citations
9.
Wichman, Alison, et al.. (2000). Research Involving Persons with Cognitive Impairments: Results of a Survey of Alzheimer Disease Research Centers in the United States. Alzheimer Disease & Associated Disorders. 14(1). 20–27. 20 indexed citations
10.
Krantz, David S., et al.. (1996). The impact of disease severity on the informed consent process in clinical research. The American Journal of Medicine. 100(3). 261–268. 140 indexed citations
11.
Wichman, Alison & Robin Foà. (1996). Ethics education in neurology residency programs. Neurology. 46(5). 1481–1481. 8 indexed citations
12.
Wichman, Alison, et al.. (1995). Research involving subjects with dementia and other cognitive impairments. Neurology. 45(9). 1777–1778. 10 indexed citations
13.
Candilis, Philip J., et al.. (1993). A Survey of Researchers Using a Consent Policy for Cognitively Impaired Human Research Subjects. IRB Ethics and Human Research. 15(6). 1–1. 9 indexed citations
14.
Wichman, Alison, et al.. (1991). Bioethics at the National Institutes of Health. Kennedy Institute of Ethics journal. 1(3). 257–262. 1 indexed citations
15.
DeRenzo, Evan G. & Alison Wichman. (1990). A Pilot Project: Bioethics Consultants as Non-Voting Members of IRBs at the National Institutes of Health. IRB Ethics and Human Research. 12(6). 6–6. 3 indexed citations
16.
Yarchoan, Robert, Rose V. Thomas, Jordan Grafman, et al.. (1988). Long-term administration of 3?-Azido-2?,3?-dideoxythymidine to patients with AIDS-related neurological disease. Annals of Neurology. 23(S1). S82–S87. 72 indexed citations
17.
Wichman, Alison, Fritz Buchthal, G. Pezeshkpour, & Richard E. Gregg. (1986). Vitamin E deficiency in neuropathy of abetalipoproteinemia. Neurology. 36(7). 1009–1009. 1 indexed citations
18.
Wichman, Alison, Fritz Buchthal, G. Pezeshkpour, & Anthony S. Fauci. (1985). Peripheral neuropathy in hypereosinophilic syndrome. Neurology. 35(8). 1140–1140. 37 indexed citations
19.
Wichman, Alison, Fritz Buchthal, G. Pezeshkpour, & Richard E. Gregg. (1985). Peripheral neuropathy in abetalipoproteinemia. Neurology. 35(9). 1279–1279. 38 indexed citations
20.
McKeever, Paul E., et al.. (1984). Sarcoma Arising From a Gliosarcoma. Southern Medical Journal. 77(8). 1027–1032. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026